(Q45255770)

11 December 2017

title

Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection (English)

1 reference

11 December 2017

0 references

1 reference

1 reference

1

1 reference

11 December 2017

Marie-Louise Essink-Bot

series ordinal

4

1 reference

11 December 2017

5

Peter D Siersema

1 reference

11 December 2017

Marjolein Y V Homs

2

1 reference

11 December 2017

Annemieke Stokvis

series ordinal

3

1 reference

11 December 2017

SIREC Study Group

series ordinal

6

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

Gastrointestinal Endoscopy

11 December 2017

published in

1 reference

11 December 2017

volume

62

1 reference

11 December 2017

issue

3

1 reference

11 December 2017

page(s)

333-340

1 reference

Cancer burden in the year 2000. The global picture

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Palliation of patients with esophagogastric neoplasms by insertion of a covered expandable modified Gianturco-Z endoprosthesis: experiences in 153 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

A single session of intraluminal brachytherapy in palliation of oesophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Palliation of malignant dysphagia and fistulae with coated expandable metal stents: experience with 101 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Cost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Palliative treatment by high-dose-rate intraluminal brachytherapy in patients with advanced esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

The role of photodynamic therapy (PDT) in inoperable oesophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

High dose rate brachytherapy for the palliation of malignant dysphagia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

A new design metal stent (Flamingo stent) for palliation of malignant dysphagia: a prospective study. The Rotterdam Esophageal Tumor Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Results of radiotherapy for inoperable locally advanced esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Results of external irradiation and low-dose-rate intraluminal brachytherapy for esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Multiple fraction per day radiation therapy for inoperable esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Evaluation of the palliative effect of radiotherapy for esophageal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

The effect of radiotherapy on dysphagia and survival in patients with esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Regression models in clinical studies: determining relationships between predictors and response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Toxicity and response criteria of the Eastern Cooperative Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Subgroup analysis and other (mis)uses of baseline data in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Probabilistic prediction in patient management and clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Regression modelling strategies for improved prognostic prediction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

Assessing the generalizability of prognostic information

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901587-7

10.1016/S0016-5107(05)01587-7

7 January 2021

Identifiers

DOI

1 reference

11 December 2017

1 reference